Thermo Fisher Scientific, Inc. (TMO) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (reve...
Thermo Fisher Scientific, Inc. (TMO) currently trades at a P/E ratio of 33.96 (historical range: 22.71–38.62, median: 31.01), placing it at the 80th percentile — expensive relative to its history, P/S ratio of 5.15 (range: 3.45–5.65, 85th percentile — expensive relative to its history), EV/EBITDA of 146.26 (range: 26.44–148.60, 99th percentile).
Thermo Fisher Scientific, Inc. appears overvalued relative to its own historical valuation range, trading at elevated multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 33.96 | 22.71 | 31.01 | 38.62 | 80th | expensive relative to its history |
| P/S Ratio | 5.15 | 3.45 | 4.63 | 5.65 | 85th | expensive relative to its history |
| EV/EBITDA | 146.26 | 26.44 | 51.28 | 148.60 | 99th | expensive relative to its history |
| FCF Yield | 0.00 | 0.00 | 0.01 | 0.04 | 13th | expensive relative to its history |